http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/ What is Vioxx? Vioxx was marketed by Merck & Co., before it was pulled from the worldwide market. Vioxx, also known by the generic name of rofecoxib, was voluntarily withdrawn by Merck on September 30, 2004. Merck mounted a very aggressive marketing campaign for Vioxx when it was first introduced to the market, resulting in enormous revenues from the sales of the drug. In 2003, Merck enjoyed Vioxx sales of approximately $2.5 billion. An estimated 84 million people worldwide have used Vioxx since it was introduced, and Vioxx was one of the most frequently prescribed drugs in the United States. Due ... en-us http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature. http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/ Merck & Co.'s painkiller Vioxx contributed to an Idaho postal worker's heart attack, a jury in Atlantic City ruled Monday, reversing the verdict in the man's first trial and awarding him and his wife... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/Merck's former painkiller Vioxx contributed to the heart attack of an Idaho postal worker, a state jury in Atlantic City ruled Monday. The jury awarded Frederick "Mike" Humeston and his wife $20 milli... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/Sept. 13 (Bloomberg) -- Merck & Co.'s experimental painkiller, Arcoxia, may carry the same risk of heart attacks and strokes as Vioxx, according to an analysis of 23 studies comparing side effects of ... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/ Judith Levy submits: Excerpt from our One Page Annotated Wall Street Journal Summary : Merck's Vioxx Tied to New Threat; Heart Risks Start Early in Study Summary: Two studies published online yesterd... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/A paper published Tuesday suggests that Vioxx posed heart risks that a similar drug, Celebrex, does not. http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/CHICAGO (Reuters) -- Two studies offer more evidence about the dangers of some painkillers, adding kidney problems to heart concerns already raised with the drug once sold as Vioxx, researchers said o... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/ TUESDAY, Sept. 12 (HealthDay News) -- Two studies suggest that the banned prescription painkiller Vioxx was more dangerous for users than its two cox-2 inhibitor rivals, Bextra, also withdrawn, and t... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/Seeger Weiss LLP announces that the jury verdict rendered in favor of Merck & Co. (NYSE: <a href="http://www.google.com/finance?q=MRK">MRK</a>) in the Vioxx-related trial entitled, <u>Humeston v. Merck</u>, has been vac... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/ Merck & Co. on Thursday suffered a double setback when a federal jury awarded $51 million to a former user of its withdrawn pain medicine Vioxx, and a New Jersey judge threw out a Vioxx verdict that ... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/ A federal jury on Thursday found that Merck & Co. Inc. was negligent and knowingly made misrepresentations about its withdrawn pain medicine Vioxx, and awarded $51 million to the plaintiff. http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/The judge in the first Vioxx case Merck won tosses the case on new evidence. http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/ Merck & Co. on Thursday suffered a double setback when a federal jury awarded $51 million to a former user of its withdrawn pain medicine Vioxx, and a New Jersey judge threw out a Vioxx verdict that ... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/ A federal jury on Thursday found that Merck & Co. Inc. was negligent and knowingly made misrepresentations about its withdrawn pain medicine Vioxx, and awarded $51 million to the plaintiff. http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/The judge in the first Vioxx case Merck won tosses the case on new evidence. http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/Merck & Co. did not inform federal authorities about two clinical trials in which users of the painkiller Vioxx were more likely to die than people given a placebo, jurors in the first Vioxx liability... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/ A correction published Monday by a medical journal to a key study on withdrawn painkiller Vioxx reveals the risk of heart problems was elevated throughout the time people took the drug and did not de... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/ A federal trial over the now-defunct drug Vioxx begins Monday in New Orleans. The case involves a New Orleans man who suffered a heart attack after taking the drug. Merck, the maker of Vioxx, is choo... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/ Drug maker Merck & Co. repeatedly tried to downplay the cardiac risks of its painkiller Vioxx, so user Elaine Doherty didn't know about them and couldn't control them before she suffered a heart atta... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/ A jury of five women and five men was selected Friday in Atlantic City for the seventh trial against drug maker Merck & Co. over its withdrawn arthritis drug Vioxx. http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/May 31 (Bloomberg) -- A U.S. Food and Drug Administration whistleblower who claimed Merck & Co.'s Vioxx painkiller caused 140,000 heart attacks and strokes testified that co-workers at his agency trie... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/Merck said that it erred when it reported in early 2005 that a crucial statistical test showed that Vioxx caused heart problems only after 18 months of continuous use. http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/Merck, the no. 2 drugmaker in America, said on Tuesday that it made a correction to the study that led to the withdrawal of its arthritis painkiller Vioxx, but that it didn't change the results of the... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/A Canadian study involving thousands of Vioxx patients concluded they faced the highest risk of heart attack during the first few weeks of taking Merck's arthritis painkiller. http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/May 2 (Bloomberg) -- Merck & Co.'s Vioxx painkiller may raise the risk of a heart attack within two weeks after patients start taking the drug, earlier than previous studies have shown, according to C... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/ Jurors in Merck & Co.'s Vioxx trial awarded $4.5 million on Wednesday to a 77-year-old New Jersey man after finding the painkiller contributed to his heart attack, casting doubts on the strategy Merc... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/A government whistle-blower who criticized the Food and Drug Administration's handling of Vioxx will be deposed, giving evidence that could aid thousands of lawsuits over the withdrawn painkiller. http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/Two more federal lawsuits claiming the painkiller Vioxx caused heart attacks or other cardiovascular problems are scheduled for trial in the next few months. http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/Round Two of the first U.S. federal trial challenging safety of Merck & Co.'s drug Vioxx will be Feb. 6 in New Orleans, a judge has told attorneys. U.S. District Judge Eldon Fallon of New Orleans http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/The COX-2 inhibitor Vioxx, which Merck withdrew from the market in 2004 over safety concerns, "might be doing some good in limited use today, if only the FDA had slowed the approval process enough for... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Vioxx-P57/News/In an apparent setback for Merck, a federal judge in Houston has declared a mistrial in Plunkett v. Merck, the third Vioxx lawsuit to reach trial, after jurors said they were hopelessly deadlocked.